We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BIO3 market cap is 510.47M. The company's latest EPS is EUR 6.3388 and P/E is 6.53.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 419.1M | 484.2M | 515.6M | 516.1M | 684.6M |
Operating Income | 1.8M | -1.8M | -45.8M | -17.7M | 146.2M |
Net Income | -5.49M | -32.19M | -64.19M | -31.7M | 125.42M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 1.11B | 1.13B | 1.1B | 1.2B | 1.41B |
Total Liabilities | 631.5M | 689.7M | 723.8M | 831.9M | 912M |
Total Equity | 476.9M | 441.6M | 380.4M | 371.1M | 498.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -33.6M | -16.7M | 33.9M | -40.5M | -2.7M |
Investing | -8M | -14.6M | -23.4M | -37M | 1.3M |
Financing | 40.5M | 42M | 22.6M | 89.6M | -6.8M |
Market Cap | 510.47M |
Price to Earnings Ratio | 6.53 |
Price to Sales Ratio | 1.2 |
Price to Cash Ratio | 7.58 |
Price to Book Ratio | 1.64 |
Dividend Yield | 0.16% |
Shares Outstanding | 19.79M |
Average Volume (1 week) | 60 |
Average Volume (1 Month) | 182 |
52 Week Change | -16.77% |
52 Week High | 31.20 |
52 Week Low | 22.60 |
Spread (Intraday) | 0.7 (2.68%) |
Company Name | Biotest AG |
Address |
landsteinerstrasse 5 dreieich 63303 |
Website | https://www.biotest.de |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions